Symbol="CBAY"
AssetType="Common Stock"
Name="Cymabay Therapeu"
Description="CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering therapies to treat liver and other chronic diseases. The company is headquartered in Newark, California."
CIK="1042074"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3876 BAY CENTER PLACE, HAYWARD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1281840000"
EBITDA="-71037000"
PERatio="None"
PEGRatio="0"
BookValue="1.108"
DividendPerShare="0"
DividendYield="0"
EPS="-0.89"
RevenuePerShareTTM="0.33"
ProfitMargin="-2.603"
OperatingMarginTTM="-2.315"
ReturnOnAssetsTTM="-0.222"
ReturnOnEquityTTM="-0.846"
RevenueTTM="31016000"
GrossProfitTTM="-41635000"
DilutedEPSTTM="-0.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="17.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="5.76"
EVToRevenue="-"
EVToEBITDA="-3.032"
Beta="0.377"
num_52WeekHigh="14.19"
num_52WeekLow="3.155"
num_50DayMovingAverage="10.99"
num_200DayMovingAverage="8.33"
SharesOutstanding="98150000"
DividendDate="None"
ExDividendDate="None"
symbol="CBAY"
open="13.64"
high="13.64"
low="12.76"
price="13.20"
volume="2066011.00"
latest_trading_day="2023-08-25"
previous_close="13.57"
change="-0.37"
change_percent="-2.7266%"
aroon_positive_momentum_days="85"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="1734567"
Change_recent_avg="0.02"
Delta_recent_avg="0.56"
Variance_recent_avg="0.28"
Change_ratio_recent_avg="0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="1151"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="692"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_positive_thumbnail_id_2="704"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
